Lung cancer is the most common malignancy worldwide, accounting for one fifth of all cancer-related deaths ([@R1]). There are different trends of lung cancer incidence and mortality throughout Europe, mostly reflecting different phases of smoking epidemic in individual countries. In many European countries, the rates in men have recently decreased or stabilized, while the rates in women increased ([@R2]-[@R4]). Because the majority of lung cancer deaths are attributed to tobacco smoking, any decline or deceleration in the lung cancer death rates could be attributed to the past antismoking interventions ([@R5],[@R6]). Early indicators of progress in tobacco-smoking control are lung cancer trends in young adults ([@R6]).

About 90% of lung cancers in men and 83% in women are caused by smoking ([@R7]). The risk of developing lung cancer is affected by the level of consumption and duration of smoking ([@R8]), as well as the level of exposure to environmental tobacco smoke ([@R9]). The second most important cause of lung cancer is radon, which was estimated to be responsible for 9% of lung cancer deaths in European countries ([@R10]). Other risk factors include exposure to asbestos ([@R11]), silica ([@R12]), nitrogen oxides ([@R13]), radiation to the chest as part of the treatment of malignant diseases ([@R14]-[@R16]), and scarring on the lungs due to tuberculosis or recurrent pneumonia ([@R17]).

Currently in Croatia, lung cancer is the most common cancer in men and the fifth most common cancer in women, accounting for more than 2000 and 600 deaths per year, respectively ([@R18],[@R19]). The aim of this study was to provide an overview of the temporal trends of lung cancer incidence and mortality in Croatia for the period 1988-2008.

Materials and methods
=====================

Data sources
------------

Incidence data for the period 1988-2008 were obtained from the Croatian National Cancer Registry. The Registry, founded in 1959, covers the whole Croatian population (approximately 4.4 million persons) and relies on mandatory cancer notifications from primary and secondary health care sources and death certificates from the Croatian Bureau of Statistics. The Registry has contributed data to the last three volumes of the Cancer Incidence in Five Continents series ([@R20]-[@R22]). In addition to incidence data, these publications report respective indices of data quality (proportion of morphologically verified cases, proportion of cases registered from death certificates only, and mortality to incidence ratio) ([@R20]-[@R22]). Lung cancer was defined as ICD-10 codes C33 and C34 and ICD-9 code 162. The number of lung cancer deaths was obtained from the World Health Organization (WHO) mortality database ([@R19]). Population estimates from Population Division of the Department of Economic and Social Affairs of the United Nations were used for calculating all incidence and mortality rates ([@R23]).

Statistical analysis
--------------------

Age-standardized rates of cancer incidence in Croatia and truncated age-standardized rates (for ages 30-64) were calculated by the direct standardization method, using the world standard population as a reference ([@R24]). To describe incidence and mortality time trends, we carried out joinpoint regression analysis using the software Joinpoint Regression Program, Version 3.5.2, October 2011. The analysis included logarithmic transformation of the rates, standard error, maximum number of five joinpoints, and minimum of four years between two joinpoints. All other program parameters were set to default values. The aim of the approach is to identify possible joinpoints where a significant change in the trend occurs. The method identifies joinpoints based on regression models with 0-5 joinpoints. The final model selected was the most parsimonious of these, with the estimated annual percent change (EAPC) based on the trend within each segment ([@R25]). To quantify the trend over the whole period, the average annual percent change (AAPC) was calculated. The AAPC is computed as a geometric weighted average of the EAPC trend analysis, with the weights equal to the lengths of each segment during the pre-specified fixed interval. If an AAPC lies entirely within a single joinpoint segment, the AAPC is equal to the EAPC for that segment. In these cases we reported the EAPCs ([@R26]).

In describing trends, the terms "significant increase" or "significant decrease" signify that the slope of the trend was statistically significant (*P* \< 0.05). For non-statistically significant trends (*P* \> 0.05), we used the terms "stable" (for EAPC between -0.5% and 0.5%), "non-statistically significant increase" (for EAPC\>0.5%), and "non-statistically significant decrease" (for EAPC\<-0.5%). All statistical tests were two sided.

Results
=======

Men
---

The number of new lung cancer cases in men remained stable ([Table 1](#T1){ref-type="table"}). Crude incidence rates did not change and age-standardized rates (ASR) declined ([Figure 1](#F1){ref-type="fig"}). Lung cancer age-standardized incidence rates in men decreased by one fifth, from 75.1/100 000 in the first five years (1988-1992) to 59.6/100 000 in the last five years (2004-2008). Mortality age-standardized rates in men changed from 66.5/100 000 in the first five years (1988-1992) to 57.6/100 000 in the last five years (2004-2008), with an overall percent change of -13.4%. Joinpoint analysis ([Table 2](#T2){ref-type="table"}) showed a significant decrease in the incidence, with EAPC of -1.3% (95% confidence interval \[CI\], -1.7% to -0.9%). For mortality, joinpoint analysis ([Table 3](#T3){ref-type="table"}) identified three trends. From 1988 to 1995, mortality significantly decreased, with EAPC of -2.6% (95% CI, -3.4% to -1.8%). From 1998 onwards, there was a non-significant increase of 2.1% (95% CI, -3.9% to 8.5%) followed by another decreasing trend of -0.9% (95% CI, -1.3% to -0.4%). AAPC was -1.1% (95% CI, -1.9% to -0.2%). Analysis by ten-year age groups revealed that both incidence and mortality rates decreased significantly for all age groups \<70 years old during the study period ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

###### 

Lung cancer incidence and mortality in Croatia in the period 1988-2008. Number of cases, crude rate, and age standardized rate per 100 000

  Year     Incidence   Mortality                         
  -------- ----------- ----------- ------ ------ ------- ------
  Men:                                                   
  1988     2115        97.4        77.3   1866   85.9    68.9
  1989     2149        98.7        76.5   1848   84.9    67.0
  1990     2307        105.6       80.7   1944   89.0    68.4
  1991     2074        94.3        72.0   1900   86.4    66.0
  1992     2051        92.5        69.0   1843   83.2    62.2
  1993     2236        100.1       72.2   1880   84.2    61.2
  1994     2080        92.6        65.2   1893   84.3    59.7
  1995     2142        95.2        65.9   1848   82.1    57.1
  1996     2343        104.4       71.0   1973   87.9    59.7
  1997     2354        105.7       70.7   2050   92.0    61.4
  1998     2167        98.2        64.4   2095   94.9    62.2
  1999     2394        109.5       71.0   2070   94.7    60.9
  2000     2457        113.2       71.7   2000   92.2    58.3
  2001     2418        112.0       70.0   2161   100.1   62.1
  2002     2351        109.3       67.0   2102   97.7    59.6
  2003     2219        103.4       62.5   2110   98.3    59.1
  2004     2152        100.5       59.5   2123   99.1    58.6
  2005     2346        109.7       64.7   2086   97.6    57.2
  2006     2181        102.2       60.2   2145   100.5   58.5
  2007     2217        104.1       59.7   2170   101.9   57.8
  2008     2024        95.2        53.9   2139   100.6   56.0
  Women:                                                 
  1988     342         14.8        9.0    307    13.3    8.0
  1989     383         16.5        9.7    347    15.0    8.6
  1990     441         18.9        11.3   341    14.6    8.5
  1991     400         17.0        10.0   350    14.9    8.8
  1992     386         16.3        9.2    367    15.5    8.6
  1993     389         16.2        9.0    319    13.3    7.3
  1994     408         16.9        9.4    346    14.3    8.0
  1995     410         17.0        9.1    342    14.1    7.6
  1996     507         21.0        11.1   417    17.3    9.0
  1997     480         20.0        10.3   401    16.7    8.5
  1998     439         18.5        9.3    474    20.0    9.9
  1999     525         22.3        11.2   425    18.1    8.8
  2000     589         25.2        12.9   478    20.5    10.4
  2001     542         23.3        11.7   455    19.6    9.6
  2002     590         25.5        12.8   496    21.4    10.3
  2003     555         24.0        11.8   530    22.9    10.9
  2004     586         25.4        12.0   512    22.2    10.9
  2005     654         28.4        13.5   554    24.1    11.0
  2006     664         28.9        14.3   572    24.9    11.7
  2007     569         24.8        11.7   583    25.4    11.8
  2008     514         22.4        10.4   611    26.7    12.3

\*ASR (W) -- age standardized rate (using world standard population).

![Joinpoint analyses of incidence (rhombs) and mortality (triangles) for lung cancer in Croatian men, 1988-2008. ASR (W) -- age standardized rate (using world standard population).](CroatMedJ_53_0093-F1){#F1}

###### 

Joinpoint analysis of age-specific and age-standardized rates of lung cancer incidence in Croatia (1988-2008)

  Age (years)         Trend 1     Trend 2     Trend 3     AAPC (1988-2008)                          
  ------------------- ----------- ----------- ----------- ------------------ ----------- ---------- ---------
  Men:                                                                                              
  30-39               1988-2008   \- 6.3^†^                                                         -6.3^†^
  40-49               1988-2000   0.9         2000-2008   \- 5.5^†^                                 -1.7^†^
  50-59               1988-1995   \- 4.7^†^   1995-2008   \- 0.6                                    -2.0^†^
  60-69               1988-2001   \- 0.9^†^   2001-2008   \- 3.8^†^                                 -2.0^†^
  70-79               1988-1995   \- 0.6      1995-2001   3.4                2001-2008   \- 3.4\*   -0.4
  \>80                1988-2008   0.1                                                               0.1
  Age standardized:                                                                                 
  overall             1988-2008   \- 1.3^†^                                                         -1.3^†^
  truncated (30-64)   1988-2008   \- 2.0^†^                                                         -2.0^†^
  Women:                                                                                            
  30-39               1988-2008   \- 3.2^†^                                                         -3.2
  40-49               1988-2008   1.9^†^                                                            1.9^†^
  50-59               1988-2008   3.5^†^                                                            3.5\*
  60-69               1988-2008   1.0^†^                                                            1.0^†^
  70-79               1988-2004   2.7^†^      2004-2008   \- 6.8                                    0.7
  \>80                1988-2008   1.3^†^                                                            1.3^†^
  Age standardized                                                                                  
  overall             1988-2008   1.7^†^                                                            1.7^†^
  truncated (30-64)   1988-2008   2.2^†^                                                            2.2^†^

\*EAPC -- estimated annual percent change; AAPC -- average annual percent change.

†Statistically significant trend.

###### 

Joinpoint analysis of age-specific and age-standardized rates of lung cancer mortality in Croatia (1988-2008)

  Age (years)         Trend 1     Trend 2   Trend 3     AAPC (1988-2008)                         
  ------------------- ----------- --------- ----------- ------------------ ----------- --------- ---------
  Men:                                                                                           
  30-39               1988-2008   -8.7^†^                                                        -8.7^†^
  40-49               1988-2000   0.2       2000-2008   -4.3^†^                                  -1.6
  50-59               1988-2000   -3.2^†^   2000-2008   1.2                                      -1.5^†^
  60-69               1988-1993   -2.8^†^   1993-1999   0.8                1999-2008   -2.2^†^   -1.5^†^
  70-79               1988-1995   -1.5      1995-2002   3.1^†^             2002-2008   -0.4      0.4
  \>80                1988-1995   -4.8      1995-2008   3.3^†^                                   0.4
  Age standardized:                                                                              
  overall             1988-1995   -2.6^†^   1995-1998   2.1                1998-2008   -0.9^†^   -1.1^†^
  truncated (30-64)   1988-2008   -1.8^†^                                                        -1.8^†^
  Women:                                                                                         
  30-39               1988-2008   -1.2                                                           -1.2
  40-49               1988-2008   2.9^†^                                                         2.9^†^
  50-59               1988-2008   2.7^†^                                                         2.7^†^
  60-69               1988-2008   2.1^†^                                                         2.1^†^
  70-79               1988-2008   2.0^†^                                                         2.0^†^
  \>80                1988-2008   2.2^†^                                                         2.2^†^
  Age standardized:                                                                              
  overall             1988-1994   -1.0      1994-2008   3.1^†^                                   1.9^†^
  truncated (30-64)   1988-2008   2.7^†^                                                         2.7^†^

\*EAPC -- estimated annual percent change; AAPC -- average annual percent change.

†Statistically significant trend.

Women
-----

In women, there was an increase in the number of cases and ASRs ([Figure 2](#F2){ref-type="fig"}). Age-standardized incidence rates increased by 26.5%, from 9.8/100 000 in the first five-years (1988-1992) to 12.4/100 000 in the last five-years (2004-2008). Mortality age-standardized rates increased by 35.3%, from 8.5/100 000 in the first five years (1988-1992) to 12.5/100 000 in the last five years (2004-2008). Joinpoint analysis showed a significantly increasing trend of incidence, with EAPC of 1.7% (95% CI, 0.8% to 2.5%) ([Table 2](#T2){ref-type="table"}). Joinpoint analysis of mortality ([Table 3](#T3){ref-type="table"}) identified one joinpoint in 1994. The first trend showed non-significant decrease, with EAPC of -1.0% (95% CI, -4.1% to 2.2%), followed by a significant increase, with EAPC of 3.1% (95% CI, 2.3% to 3.9%) from 1994 to the end of the study period. AAPC was 1.9% (95% CI, 0.9% to 2.9%) throughout the whole period. Analysis by ten-year age groups showed that both incidence and mortality increased significantly in all age groups older than 40 years and decreased in younger women (30-39 years). ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"})

![Joinpoint analyses of incidence (rhombs) and mortality (triangles) for lung cancer in Croatian women, 1988-2008. ASR (W) -- age standardized rate (using world standard population).](CroatMedJ_53_0093-F2){#F2}

Discussion
==========

This study confirmed the findings that, despite the overall decreasing trend, Croatia is still among the European countries with the highest male lung cancer incidence and mortality rate ([@R27],[@R28]). With male ASR incidence and mortality of 59.6 and 57.6/100 000 men, respectively, it is in the top five of the 40 analyzed European countries. Hungary has the highest estimated male ASR of mortality, of 73.5/100 000, while Cyprus has the lowest, of 21.3/100 000. Incidence and mortality in women are considerably lower. Compared to other European countries, Croatia has an intermediate incidence and mortality rate (12.4 and 12.5/100 000, respectively). Denmark has the highest mortality rate of 30/100 000 and Belarus the lowest -- 3.7/100 000 ([@R28]).

More than a quarter of all adult inhabitants of Croatia are every-day smokers ([@R29]). A survey conducted in 1972 showed a prevalence of daily cigarette smoking of 56.9% in men and 10.1% in women. In the period between 1972 and 1997, the prevalence decreased among men and increased among women. During the last decade, there has been a reduction in the frequency of smokers of both sexes ([@R29],[@R30]). Our results show that lung cancer incidence and mortality rates in men have been constantly decreasing in most of the age groups. This trend is in agreement with the decrease in the prevalence of male smokers observed during the same period ([@R29]). On the other hand, women showed an increasing incidence trend, although their age standardized incidence rates are still 5 times lower than those of men. This increasing incidence trend follows the increase in the prevalence of female smokers ([@R29]) and reflects a lung cancer epidemic in women. Still, though not significant, we observed a stabilization and beginning of a decreasing trend in younger women (30-39 years). Together with the initial reduction in the frequency of smokers among women during the last decade ([@R30]), this might be an early indicator that lung cancer incidence and mortality in women will reach a plateau or start declining in the future. The trends in Croatia are similar to those in most European countries. The mortality trends in men are largely encouraging, since there are general declines in most European countries, particularly during the last two decades, while there are still increases in parts of Southern (Portugal and the Republic of Macedonia) and Eastern Europe (Bulgaria, Romania, and Moldova) ([@R27]). Among women, mortality rates have reached a plateau or are beginning to decline in a number of Eastern European countries (Hungary, Poland, and the Czech Republic), and in Northern Europe (Denmark, Iceland, and the United Kingdom), which reflects recent changes in smoking habits. The trends in Western Europe (France and the Netherlands) and Southern Europe (Spain) are increasing ([@R27]).

Croatia still bears a major smoking-related health burden. Some of the most obvious barriers to implementing successful smoking prevention program initiatives include very limited resources, recent transnational tobacco industry's interest in the Croatian market, and the social acceptability of smoking. By ratifying the Framework Convention for Tobacco Control, Croatia did integrate European tobacco bans, but smoking is still allowed in most of the bars and cafes ([@R31]). Because of a large number of older Croatians who have been smoking for decades, the rise in the number of tobacco-related deaths is expected to continue ([@R31]). Such trends encourage the implementation of smoking prevention and cessation policies, particularly those targeting younger population, especially women.
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